Diary Prequel Package — page 112

can now protect every man, woman in child if this vicious disease were to return. * We protected America from SARS and we helped the world understand this mysterious disease so we could contain its spread. * We're leading the world to prepare for a world flu pandemic and Avian flu. * And, together with our public health partners, we have helped this nation manage an unexpected influenza vaccine shortage. That is quite a record in four short years. You all should be proud. And, best of all, we are working together more closely than ever before to better serve American families. We truly are One Department - with the best and brightest working together across agencies to solve our nation's toughest problems. And we truly are the Department of Compassion. I will miss you all more than you can ever know. I will forever cherish the friendships I made here the last four years. And I will always be in awe of the talent, dedication and drive of the people of the Department of Health and Human Services. Keep leading this nation forward. Keep putting the well-being of our people first. And keep changing the status quo in search of a better way. You will always be in my prayers and in my heart. With gratitude and friendship, Tommy G. Thompson Dec. 20, 2004 - Terrible time over the past couple of weeks with a 4 part story by an AP reporter on the Jonathan Fishbein issue and the HIVNET 012 story. Fishbein is a Title 42 on a 2 year probation period in DAIDS. His performance was terrible and Ed Tramont and Jon Kagan decided to remove him. He got a high-priced whistleblower lawyer and claimed whistleblower status despite the fact that he "blew the whistle" AFTER he was informed that he would be removed. He leaked internal documents regarding the technical difficulties with HIVNET 012 (use of nevirapine for prevention of mother-tochild transmission (MTCT) of HIV. In that landmark trial it was shown that the drug in a single dose was safe and effective for prevention of MTCT. The use in these circumstances has likely saved tens of thousands of children's lives in developing countries, particularly sub-Saharan Africa. The paper appeared in Lancet in 1999 and several papers have corroborated the safety and efficacy of Nev. For MTCT prevention. Since the results of the trial (HIVNET 012) were so striking, the maker of Nev (BI) decided to use the data from the trial to expand the licensed indication of Nev to MTCT